Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Cybulska P, Goss C, Tew WP, Parameswaran R, Sonoda Y. Indications for and complications of transfusion and the management of gynecologic malignancies. Gynecol Oncol. 2017;146(2):416-426.

Jimenez A, Shaz BH, Bloch EM. Zika Virus and the Blood Supply: What Do We Know? Transfus Med Rev. 2017;31(1):1-10.

Yanagida K, Liu CH, Faraco G, Galvani S, Smith HK, Burg N, et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc Natl Acad Sci U S A. 2017;114(17):4531-4536.

Magro CM, Saab J. Lymphocytic thrombophilic arteritis: A distinct inflammatory type I interferon and C5b-9 mediated subcutaneous endovasculitis. Ann Diagn Pathol. 2017;31:23-29.

Schwartz Z, Coleman M, Toyohara JP, Freedman PD, Magro CM. Oral Lymphomatoid papulosis type C: A diagnostic pitfall, often confused with T-cell lymphoma. Ann Diagn Pathol. 2017;31:50-55.

Dinerman BF, Bernstein AN, Khani F, Hu JC. Intraductal Carcinoma of the Prostate: A Risk for Rapid Recurrence. Urology. 2017;105:e1-e2.

Meliti A, Sadimin E, Diolombi M, Khani F, Epstein JI. Accuracy of Grading Gleason Score 7 Prostatic Adenocarcinoma on Needle Biopsy: Influence of Percent Pattern 4 and Other Histological Factors. Prostate. 2017;77(6):681-685.

Guerrero-Preston R, White JR, Godoy-Vitorino F, Rodríguez-Hilario A, Navarro K, González H, et al. High-resolution microbiome profiling uncovers , , and associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation. Oncotarget. 2017;8(67):110931-110948.

Singh DK, Kollipara RK, Vemireddy V, Yang X-, Sun Y, Regmi N, et al. Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. Cell Rep. 2017;18(4):961-976.

Mostaghel EA, Cho E, Zhang A, Alyamani M, Kaipainen A, Green S, et al. Association of Tissue Abiraterone Levels and Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer. Clin Cancer Res. 2017;23(16):4592-4601.